Nosocomial Infection

A nosocomial infection (from Greek nosokomeion, "hospital"), also termed a healthcare-associated infection (HAI) or hospital-acquired infection, is an infection acquired by a patient while receiving diagnostic, medical, or surgical care in a hospital, intensive care unit (ICU), outpatient surgical center, or long-term care facility that was neither clinically present nor in its incubation period at the time of admission (conventionally defined for acute bacterial infections as manifesting ≥48 hours after hospital admission, within 3 days of discharge, or within 30 to 90 days after a surgical procedure). Across high-income countries, approximately 4% to 7% of all hospitalized patients (and 10% to 15% in low- and middle-income countries, rising to 30% in adult and neonatal intensive care units) acquire at least one nosocomial infection during their stay—accounting for an estimated 1.7 million infections and 99,000 attributable deaths annually in the United States alone, and 3.5 million infections and >90,000 deaths annually in the European Union (Klevens et al., 2007; Magill et al., 2018; WHO, 2011). First proven to be iatrogenic and preventable in May 1847 when Hungarian obstetrician Ignaz Philipp Semmelweis introduced chlorinated-lime hand scrubbing at the Vienna General Hospital (Allgemeines Krankenhaus) and slashed maternal puerperal fever (Streptococcus pyogenes) mortality from 18.3% down to 1.2%, nosocomial infections today are dominated by four invasive-device and surgical syndromes (CLABSI, CAUTI, VAP, and SSI), healthcare-associated Clostridioides difficile colitis, and the multidrug-resistant ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) (Semmelweis, 1861; Pronovost et al., 2006; Rice, 2008; Allegranzi & Pittet, 2009).

Puerperal Fever and Chlorinated Lime Antisepsis in Vienna

1. Ignaz Semmelweis and the Two Obstetrical Clinics of Vienna (1847): At the Vienna General Hospital, maternity patients were admitted on alternating days to two free clinics: the First Clinic (staffed by medical professors and students who came directly to the delivery ward after performing bare-handed morning autopsies in the deadhouse) and the Second Clinic (staffed by midwives who did not perform autopsies). Between 1841 and 1846, maternal mortality from childbed (puerperal) fever averaged 9.9% (peaking at 18.3% in April 1847) in the doctors' First Clinic versus 3.3% in the midwives' Second Clinic. When Semmelweis's friend, forensic pathologist Jakob Kolletschka, died of identical bilateral pleuritis, peritonitis, and pyemia after a student's autopsy scalpel pricked his finger, Semmelweis deduced that doctors were carrying "cadaveric particles" on their unwashed hands into the birth canal. In mid-May 1847, Semmelweis mandated that every physician and student scrub their hands with a chlorinated lime (calcium hypochlorite, Ca(OCl)₂) solution until the cadaveric odor vanished before examining any patient: maternal mortality in the First Clinic plummeted within a single month from 18.3% to 2.2%, and down to 1.27% in 1848 (Semmelweis, 1861; Pittet & Boyce, 2001).

Sanitary Reform and Carbolic Acid Surgical Antisepsis

1. Florence Nightingale (1855) and Joseph Lister (1867): During the Crimean War at the Scutari Barracks Hospital, Florence Nightingale used polar-area ("coxcomb") statistical diagrams to prove that 10 times more British soldiers were dying of hospital-acquired typhus, typhoid, and dysentery than of battlefield wounds, establishing hospital ventilation, bed spacing, and environmental sanitation. Twelve years later, inspired by Louis Pasteur's germ theory, Scottish surgeon Joseph Lister (1867) introduced carbolic acid (phenol) antisepsis of surgical instruments, wound dressings, and hands, cutting post-amputation hospital gangrene and sepsis mortality from 45% to 15%.

Invasive Medical Devices and Biofilm Antibiotic Tolerance

Why are hospitalized patients so uniquely susceptible to infection by opportunistic organisms that rarely harm healthy people in the community? Hospitalization simultaneously breaches the body's primary anatomical barriers (skin and mucosal epithelia) via indwelling polymeric catheters and endotracheal tubes, suppresses host immunity, and exposes the patient to abiotic plastic and titanium surfaces on which bacteria rapidly assemble extracellular polymeric substance (EPS) biofilms that are 100- to 1,000-fold more tolerant to antibiotics and host neutrophils than planktonic cells (Donlan & Costerton, 2002; Magill et al., 2018):

In 2008, infectious disease physician Louis B. Rice coined the acronym ESKAPE to designate the six virulent, biofilm-forming bacterial pathogens responsible for the majority of life-threatening nosocomial infections and capable of "escaping" the biocidal action of clinical antibiotics through horizontal gene transfer and chromosomal mutations (Rice, 2008):

• E — Enterococcus faecium: Intrinsically resistant to cephalosporins and aminoglycosides; acquires the vanA or vanB transposon (Tn1546) remodeling peptidoglycan D-Ala-D-Ala precursors into D-Ala-D-Lac (reducing vancomycin binding affinity 1,000-fold) to become Vancomycin-Resistant Enterococcus (VRE), which survives on dry hospital bedrails and call buttons for up to 4 months.
• S — Staphylococcus aureus: Acquires the mobile SCC*mec* cassette (mecA → PBP2a) to become Methicillin-Resistant S. aureus (MRSA); universal ICU decolonization with intranasal mupirocin + daily chlorhexidine bathing reduced MRSA clinical cultures by 37% and all-cause bloodstream infections by 44% in the 74-ICU REDUCE MRSA Trial (Huang et al., 2013).
• K — Klebsiella pneumoniae: Produces Extended-Spectrum β-Lactamases (CTX-M) and plasmid-borne carbapenemases (KPC-2/3, NDM-1, OXA-48) that hydrolyze all penicillins, cephalosporins, and carbapenems to generate Carbapenem-Resistant Enterobacterales (CRE).
• A — Acinetobacter baumannii: A desiccation-resistant Gram-negative coccobacillus (CRAB) that contaminates ICU ventilators, humidifiers, and mattresses and carries OXA-23, OXA-24, and OXA-58 carbapenemases.
• P — Pseudomonas aeruginosa: A waterborne and biofilm specialist residing in hospital sink P-traps, aerators, and respiratory equipment that combines outer-membrane OprD porin loss, MexAB-OprM efflux pumps, AmpC β-lactamase derepression, and VIM or IMP metallo-β-lactamases.
• E — Enterobacter spp. (E. cloacae complex, Klebsiella aerogenes): Carry inducible chromosomal AmpC cephalosporinases that mutate during third-generation cephalosporin therapy to cause breakthrough bacteremia.
• Emerging Fungal Threat — Candida auris: First identified in 2009, Candida auris is a thermo- and halotolerant yeast that colonizes human skin persistently (behaving epidemiologically like MRSA/Acinetobacter rather than endogenous gut Candida albicans), resists fluconazole in >90% of isolates (and increasingly echinocandins and amphotericin B), resists quaternary ammonium hospital disinfectants, and causes high-mortality ICU bloodstream outbreaks (Lockhart et al., 2017).

Why did healthcare worker hand hygiene compliance languish below 40% throughout the twentieth century despite Semmelweis's proof in 1847? At the University of Geneva Hospitals in the 1990s, Didier Pittet and colleagues (2000, The Lancet) demonstrated that traditional sink-and-soap handwashing required 60 to 90 seconds per episode (walking to a distant sink, lathering, rinsing, drying), which would consume over 16 hours of nursing time per shift in a busy ICU and caused irritant contact dermatitis.

By replacing routine soap-and-water washing (for non-visibly soiled hands) with point-of-care alcohol-based handrubs (ABHR, 60%–80% ethanol or isopropanol + 1.45% glycerol emollient)—which take only 20 to 30 seconds, denature microbial envelope proteins 100-fold more rapidly than medicated soap, and improve skin hydration—and organizing workflow around the WHO "My 5 Moments for Hand Hygiene" (1. Before touching a patient; 2. Before clean/aseptic procedures; 3. After body fluid exposure risk; 4. After touching a patient; 5. After touching patient surroundings), Pittet's team doubled hospital-wide hand hygiene compliance from 48% to 66%, cutting overall nosocomial infection prevalence by 41% and MRSA transmission rates by 57% (Pittet et al., 2000; Allegranzi & Pittet, 2009).

In 2021, national surveillance reported to the CDC National Healthcare Safety Network (NHSN) documented that extended mechanical ventilation, prone positioning, and immunomodulatory therapy during the COVID-19 critical-care waves drove a 47% increase in national central line-associated bloodstream infection (CLABSI) rates, a 45% increase in ventilator-associated events (VAP), and a 35% rise in hospital-onset carbapenem-resistant Enterobacterales (CRE) and Acinetobacter baumannii (CRAB) across acute-care hospitals (Weiner-Lastinger et al., 2022).

In 2022, revised multi-society SHEA/IDSA/APIC Compendium practice recommendations updated acute-care ventilator-associated pneumonia and event prevention bundles—de-emphasizing routine oral chlorhexidine in non-cardiac ventilated patients while prioritizing daily spontaneous awakening and breathing trials alongside subglottic secretion drainage—helping restore ICU device-associated standardized infection ratios toward pre-pandemic baselines (Klompas et al., 2022).

In 2023, NHSN and state public health surveillance analyzed by Lyman et al. confirmed that clinical cases of multidrug-resistant Candida auris in United States hospitals rose by 95% in 2021 (reaching 1,471 clinical cases and exceeding 2,300 annual clinical cases across 2022–2024) while colonization screening detections surged by 209%, accompanied by the first nosocomial clusters of echinocandin-resistant and pan-resistant C. auris carrying FKS1 hot-spot mutations and the hospital expansion of convergent hypervirulent, carbapenem-resistant Klebsiella pneumoniae clones (such as ST11, ST147, and ST23 carrying both bla_NDM/bla_KPC and aerobactin iuc virulence plasmids) (Lyman et al., 2023).

1. Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., Sauvan, V., Touveneau, S., & Perneger, T. V. (2000). Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. The Lancet, 356(9238), 1307–1312. https://doi.org/10.1016/S0140-6736(00)02814-202814-2)
2. Donlan, R. M., & Costerton, J. W. (2002). Biofilms: Survival mechanisms of clinically relevant microorganisms. Clinical Microbiology Reviews, 15(2), 167–193. https://doi.org/10.1128/CMR.15.2.167-193.2002
3. Pronovost, P., Needham, D., Berenholtz, S., Sinopoli, D., Chu, H., Cosgrove, S., ... & Goeschel, C. (2006). An intervention to decrease catheter-related bloodstream infections in the ICU. New England Journal of Medicine, 355(26), 2725–2732. https://doi.org/10.1056/NEJMoa061115
4. Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. Journal of Infectious Diseases, 197(8), 1079–1081. https://doi.org/10.1086/533452
5. Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Avery, T. R., ... & Platt, R. (2013). Targeted versus universal decolonization to prevent ICU infection. New England Journal of Medicine, 368(24), 2255–2265. https://doi.org/10.1056/NEJMoa1207290
6. Magill, S. S., O'Leary, E., Janelle, S. J., Thompson, D. L., Dumyati, G., Nadle, J., ... & Edwards, J. R. (2018). Changes in prevalence of health care–associated infections in U.S. hospitals. New England Journal of Medicine, 379(18), 1732–1744. https://doi.org/10.1056/NEJMoa1801550
7. Weiner-Lastinger, L. M., Pattabiraman, V., Konnor, R. Y., Patel, P. R., Wong, E., Xu, S. Y., ... & Dudeck, M. A. (2022). The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network. Infection Control & Hospital Epidemiology, 43(1), 12–25. https://doi.org/10.1017/ice.2021.362
8. Klompas, M., Branson, R., Cawcutt, K., Crist, M., Eichenwald, E. C., Greene, L. R., ... & Berenholtz, S. M. (2022). Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infection Control & Hospital Epidemiology, 43(6), 687–713. https://doi.org/10.1017/ice.2022.88
9. Lyman, M., Forsberg, K., Sexton, D. J., Chow, N. A., Lockhart, S. R., Jackson, B. R., & Chiller, T. (2023). Worsening spread of Candida auris in the United States, 2019 to 2021. Annals of Internal Medicine, 176(4), 489–495. https://doi.org/10.7326/M22-3469